Subclinical atrial fibrillation: Implications of recent trials for guideline updates?

Figure 4 Flow chart regarding anticoagulation approach in subclinical atrial fibrillation. The green colour indicated factors favouring direct oral anticoagulation (DOAC) use in subclinical atrial fibrillation, while the red colour represents factors arguing against DOAC therapy. The CHA₂DS₂-VASc score is used to predict the risk of ischemic stroke among patients with atrial fibrillation and ranges from 0 to 9, with higher scores indicating a greater risk of stroke. SCAF: Subclinical atrial fibrillation; CAD: Coronary artery disease; PAD: Peripheral artery disease; DOAC: Direct oral anticoagulation; CHA₂DS₂-VASc score: Congestive heart failure, hypertension, age ≥ 75 years (2 points), diabetes mellitus, prior stroke or TIA or thromboembolism (2 points), vascular disease, age 65-74 years, sex category.